Introduction to New Guidelines Preventing Augmentation In Restless Leg Syndrome
Welcome to our comprehensive guide on New Guidelines Preventing Augmentation In Restless Leg Syndrome. Ambra Stefani, MD, PhD, Medical University of Innsbruck, Innsbruck, Austria, discusses current management
New Guidelines Preventing Augmentation In Restless Leg Syndrome Comprehensive Overview
Claudia Trenkwalder, MD, University Medical Center of Göttingen, Göttingen, Germany, briefly discusses Restless legs syndrome Augmentation
Presented by John Winkelman, MD, PhD. The
Summary & Highlights for New Guidelines Preventing Augmentation In Restless Leg Syndrome
- Dr. Jeff Ratliff talks with Dr. John W. Winkelman about the
- Sponsored by the Johns Hopkins Medicine Department of Neurology and Brain Sciences Although drugs that either increase ...
- andyberkowskimd of ReLACS Health expounds on the phenomenon of
- Transdermal rotigotine (Neupro® patch) is a dopamine agonist drug in the treatment of
- Restless Legs Syndrome
In summary, understanding New Guidelines Preventing Augmentation In Restless Leg Syndrome gives us a better perspective.